Nanobiotix SA
NBTX6.430USD
-0.370-5.44%
交易中 （美东）报价延迟15分钟
304.81M总市值
--市盈率 TTM
关于 Nanobiotix SA 公司
Nanobiotix SA 是一家法国纳米医药公司。该公司设计和制造纳米粒子，可安全地增强放射疗法在癌症治疗中的疗效。它开发了利用癌细胞细胞水平的物理作用模式的新型癌症治疗工具。该公司的 NanoXray 技术包括三种产品。局部治疗（手术和放射疗法）提供了潜在的治愈方法，并使全身治疗有更好的预期寿命。NanoXray 产品是为提高肿瘤细胞放射疗法的疗效而开发的。Nanobiotix 是纽约州立大学布法罗分校的子公司。
公司简介
公司代码NBTX
公司名称Nanobiotix SA
上市日期Oct 29, 2012
CEODr. Laurent Levy, Ph.D.
员工数量108
证券类型Depository Receipt
年结日Oct 29
公司地址60 rue de Wattignies
城市PARIS
上市交易所NASDAQ Global Select Consolidated
国家France
邮编75012
电话33140260470
网址https://www.nanobiotix.com
公司代码NBTX
上市日期Oct 29, 2012
CEODr. Laurent Levy, Ph.D.
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Laurent Levy, Ph.D.
Dr. Laurent Levy, Ph.D.
Chairman of the Management Board, Chief Executive Officer, Co-Founder
Chairman of the Management Board, Chief Executive Officer, Co-Founder
--
--
Mr. Bart Van Rhijn
Mr. Bart Van Rhijn
Chief Financial Officer, Member of the Management Board
Chief Financial Officer, Member of the Management Board
--
--
Ms. Anne-Marie Graffin
Ms. Anne-Marie Graffin
Independent Vice Chairwoman of the Supervisory Board
Independent Vice Chairwoman of the Supervisory Board
--
--
Ms. Anne-Juliette Hermant
Ms. Anne-Juliette Hermant
Chief People Officer, Member of the Management Board
Chief People Officer, Member of the Management Board
--
--
Dr. Gary M. Phillips, M.D.
Dr. Gary M. Phillips, M.D.
Independent Chairman of the Supervisory Board
Independent Chairman of the Supervisory Board
--
--
Mr. Craig West
Mr. Craig West
Senior Vice President - Investor Relations
Senior Vice President - Investor Relations
--
--
Mr. Enno Spillner
Mr. Enno Spillner
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Alain Herrera
Dr. Alain Herrera
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Louis Kayitalire, M.D.
Dr. Louis Kayitalire, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Laurent Levy, Ph.D.
Dr. Laurent Levy, Ph.D.
Chairman of the Management Board, Chief Executive Officer, Co-Founder
Chairman of the Management Board, Chief Executive Officer, Co-Founder
--
--
Mr. Bart Van Rhijn
Mr. Bart Van Rhijn
Chief Financial Officer, Member of the Management Board
Chief Financial Officer, Member of the Management Board
--
--
Ms. Anne-Marie Graffin
Ms. Anne-Marie Graffin
Independent Vice Chairwoman of the Supervisory Board
Independent Vice Chairwoman of the Supervisory Board
--
--
Ms. Anne-Juliette Hermant
Ms. Anne-Juliette Hermant
Chief People Officer, Member of the Management Board
Chief People Officer, Member of the Management Board
--
--
Dr. Gary M. Phillips, M.D.
Dr. Gary M. Phillips, M.D.
Independent Chairman of the Supervisory Board
Independent Chairman of the Supervisory Board
--
--
Mr. Craig West
Mr. Craig West
Senior Vice President - Investor Relations
Senior Vice President - Investor Relations
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 5月16日 周五
更新时间: 5月16日 周五
持股股东
股东类型
持股股东
持股股东
占比
Johnson & Johnson Innovation-JJDC, Inc.
11.86%
Perceptive Advisors LLC
0.22%
Jane Street Capital, L.L.C.
0.02%
Geode Capital Management, L.L.C.
0.02%
Morgan Stanley & Co. International Plc
0.01%
Other
87.86%
持股股东
持股股东
占比
Johnson & Johnson Innovation-JJDC, Inc.
11.86%
Perceptive Advisors LLC
0.22%
Jane Street Capital, L.L.C.
0.02%
Geode Capital Management, L.L.C.
0.02%
Morgan Stanley & Co. International Plc
0.01%
Other
87.86%
股东类型
持股股东
占比
Venture Capital
11.86%
Private Equity
0.22%
Research Firm
0.04%
Investment Advisor/Hedge Fund
0.02%
Other
87.86%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
25
5.76M
12.15%
-4.19M
2025Q1
25
5.76M
12.15%
-4.19M
2024Q4
25
6.07M
12.79%
-4.24M
2024Q3
21
6.42M
13.54%
-3.89M
2024Q2
22
9.30M
19.73%
-1.04M
2024Q1
21
9.31M
19.76%
-988.94K
2023Q4
21
9.28M
19.68%
+1.01M
2023Q3
16
4.47M
12.36%
+481.67K
2023Q2
12
3.47M
9.94%
-1.27M
2023Q1
11
3.46M
9.93%
-1.28M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Johnson & Johnson Innovation-JJDC, Inc.
5.62M
11.86%
--
--
Mar 31, 2025
Perceptive Advisors LLC
105.05K
0.22%
-161.04K
-60.52%
Mar 31, 2025
Jane Street Capital, L.L.C.
11.39K
0.02%
-11.90K
-51.09%
Mar 31, 2025
Geode Capital Management, L.L.C.
10.18K
0.02%
--
--
Mar 31, 2025
Morgan Stanley & Co. International Plc
6.10K
0.01%
+1.00K
+19.61%
Mar 31, 2025
UBS Financial Services, Inc.
3.00K
0.01%
-817.00
-21.40%
Mar 31, 2025
BofA Global Research (US)
706.00
0%
-1.71K
-70.79%
Mar 31, 2025
BNP Paribas Securities Corp. North America
661.00
0%
+661.00
--
Mar 31, 2025
Citi Investment Research (US)
241.00
0%
--
--
Mar 31, 2025
RBC Capital Markets Wealth Management
136.00
0%
+7.00
+5.43%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
iShares Biotechnology ETF
0%
iShares Biotechnology ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
